- Home
- UGRO vs TLPH Comparison
UGRO vs TLPH Comparison
Compare UGRO & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UGRO | TLPH |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 37.9M |
| IPO Year | 2018 | 2010 |
Fundamental Metrics
Financial Performance| Metric | UGRO | TLPH |
|---|---|---|
| Price | $2.50 | $0.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $75.00 | $6.00 |
| AVG Volume (30 Days) | ★ 247.5K | 227.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $40,008,850.00 | $2,151,000.00 |
| Revenue This Year | $98.41 | N/A |
| Revenue Next Year | $23.34 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.11 | $0.38 |
| 52 Week High | $4.50 | $1.57 |
Technical Indicators
Market Signals| Indicator | UGRO | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 60.16 | 50.60 |
| Support Level | $0.28 | $0.86 |
| Resistance Level | $4.50 | $1.05 |
| Average True Range (ATR) | 0.42 | 0.06 |
| MACD | -0.09 | 0.02 |
| Stochastic Oscillator | 18.55 | 62.43 |
Price Performance
Historical ComparisonAbout UGRO urban-gro Inc.
Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.